Found: 22
Select item for more details and to access through your institution.
Outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type: a prospective, randomized controlled study.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 796, doi. 10.20892/j.issn.2095-3941.2020.0160
- By:
- Publication type:
- Article
Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 782, doi. 10.20892/j.issn.2095-3941.2020.0162
- By:
- Publication type:
- Article
Single-cell RNA-seq reveals the immune escape and drug resistance mechanisms of mantle cell lymphoma.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 726, doi. 10.20892/j.issn.2095-3941.2020.0073
- By:
- Publication type:
- Article
Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 753, doi. 10.20892/j.issn.2095-3941.2020.0024
- By:
- Publication type:
- Article
SHP2 promotes proliferation of breast cancer cells through regulating Cyclin D1 stability via the PI3K/AKT/GSK3β signaling pathway.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 707, doi. 10.20892/j.issn.2095-3941.2020.0056
- By:
- Publication type:
- Article
Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiation via downregulating frizzled class receptor 10.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 740, doi. 10.20892/j.issn.2095-3941.2020.0219
- By:
- Publication type:
- Article
Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 768, doi. 10.20892/j.issn.2095-3941.2020.0121
- By:
- Publication type:
- Article
An ATF<sub>24</sub> peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 676, doi. 10.20892/j.issn.2095-3941.2020.0454
- By:
- Publication type:
- Article
An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 693, doi. 10.20892/j.issn.2095-3941.2020.0010
- By:
- Publication type:
- Article
TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 664, doi. 10.20892/j.issn.2095-3941.2019.0356
- By:
- Publication type:
- Article
Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 652, doi. 10.20892/j.issn.2095-3941.2020.0063
- By:
- Publication type:
- Article
CMTM family proteins 1-8: roles in cancer biological processes and potential clinical value.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 528, doi. 10.20892/j.issn.2095-3941.2020.0032
- By:
- Publication type:
- Article
Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 626, doi. 10.20892/j.issn.2095-3941.2020.0112
- By:
- Publication type:
- Article
The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 599, doi. 10.20892/j.issn.2095-3941.2020.0102
- By:
- Publication type:
- Article
Kinetochore protein MAD1 participates in the DNA damage response through ataxia-telangiectasia mutated kinase-mediated phosphorylation and enhanced interaction with KU80.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 640, doi. 10.20892/j.issn.2095-3941.2020.0044
- By:
- Publication type:
- Article
MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 569, doi. 10.20892/j.issn.2095-3941.2020.0033
- By:
- Publication type:
- Article
Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 555, doi. 10.20892/j.issn.2095-3941.2020.0027
- By:
- Publication type:
- Article
Zinc dysregulation in cancers and its potential as a therapeutic target.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 613, doi. 10.20892/j.issn.2095-3941.2020.0106
- By:
- Publication type:
- Article
Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 583, doi. 10.20892/j.issn.2095-3941.2020.0066
- By:
- Publication type:
- Article
Active surveillance as a management strategy for papillary thyroid microcarcinoma.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 543, doi. 10.20892/j.issn.2095-3941.2019.0470
- By:
- Publication type:
- Article
COVID-19 in cancer patients: risk, clinical features, and management.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 519, doi. 10.20892/j.issn.2095-3941.2020.0289
- By:
- Publication type:
- Article
Challenges and recommendations for cancer care in the COVID-19 pandemic.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 515, doi. 10.20892/j.issn.2095-3941.2020.0300
- By:
- Publication type:
- Article